Updated results of a phase Ib/II randomised study: Polatuzumab vedotin (Pola) plus bendamustine (B) and rituximab (R) in relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL) Meeting Abstract


Authors: Sehn, L. H.; McMillan, A.; Matasar, M. J.; Flowers, C. R.; Kamdar, M.; Hertzberg, M.; Assouline, S.; Kim, T. M.; Kim, W. S.; Ozcan, M.; Croft, B.; Herrera, A. F.; Hirata, J.; Cheng, J.; Ku, G.
Abstract Title: Updated results of a phase Ib/II randomised study: Polatuzumab vedotin (Pola) plus bendamustine (B) and rituximab (R) in relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL)
Meeting Title: 60th Annual Scientific Meeting of the British Society for Haematology (BSH)
Journal Title: British Journal of Haematology
Volume: 189
Issue: Suppl. 1
Meeting Dates: 2020 Apr 27-29
Meeting Location: Birmingham, UK
ISSN: 0007-1048
Publisher: John Wiley & Sons  
Date Published: 2020-04-01
Start Page: 93
End Page: 94
Language: English
ACCESSION: WOS:000528597400129
PROVIDER: wos
PUBMED: 32337705
DOI: 10.1111/bjh.16638
Notes: Meeting cancelled due to COVID-19 pandemic -- Meeting Abstract: BSH2020-PO-081 -- Source: Wos
Altmetric
Citation Impact
MSK Authors
  1. Matthew J Matasar
    151 Matasar